Autres langues Scancell Holdings plc

Actions

Marché Fermé - London S.E. Autres places de cotation 17:35:25 26/04/2024			Varia. 5j.	Varia. 1 janv.
9,6 ^GBX	0,00 %		0,00 %	-8,57 %

26/03	Scancell administre le premier patient dans le cadre d'essais sur le mélanome	AN
22/03	Seneca Growth Capital annonce des résultats tièdes pour 2023	AN

Scancell doses first patient in melanoma-focused trials	26/03
Seneca Growth Capital announces tepid 2023 results	22/03
Scancell Holdings plc Appoints Sath Nirmalananthan to the Board	14/03
Alliance Pharma appoints chair; FireAngel sales down	05/02
Scancell's Chief Development Officer to Step Down	05/02
Scancell Holdings plc Directorate and Executive Changes Changes	05/02
Scancell interim loss narrows amid finance gain on derivative	30/01
Scancell Holdings plc Reports Earnings Results for the Half Year Ended October 31, 2023	30/01
Scancell approved by MHRA to add new cohort to Scope trial	17/01
Scancell Holdings plc Announces Update on SCOPE Trial	17/01
Scancell Raises GBP1.2 Million Via Open Offer	19/12
Scancell raises GBP12 million in total from fundraise	19/12
Scancell Raises GBP11 Million via Share Issue	01/12
Scancell raises GBP10.7 million in upsized share sale	01/12
EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen	30/11
Scancell’s Skin Cancer Vaccine Trial Advances to Second Stage; Shares Up	28/11
Scancell trial progresses; OptiBiotix inks new deal	28/11
Scancell shares up as presents "trailblazing" trial data	10/11
EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss	31/10/23
Earnings Flash (SCLP.L) SCANCELL HOLDINGS Reports FY23 Revenue GBP5.3M	31/10/23

Aucun résultat pour cette recherche